These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 35216572)

  • 1. Neuroleptic malignant-like syndrome associated multiple system atrophy: report on three cases.
    Lin Y; Ma L; Zhang N; Li R; Jiang W
    BMC Neurol; 2022 Feb; 22(1):67. PubMed ID: 35216572
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report.
    Fiore S; Persichino L; Anticoli S; De Pandis MF
    Acta Biomed; 2014 Dec; 85(3):281-4. PubMed ID: 25567468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Case of neuroleptic malignant-like syndrome precipitated by abrupt fava bean discontinuance.
    Ladha SS; Walker R; Shill HA
    Mov Disord; 2005 May; 20(5):630-1. PubMed ID: 15719433
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An uncommon adverse effect of levodopa withdrawal in a patient taking antipsychotic medication: neuroleptic malignant-like syndrome.
    Man SP
    Hong Kong Med J; 2011 Feb; 17(1):74-6. PubMed ID: 21282831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroleptic malignant syndrome without neuroleptics.
    Ong KC; Chew EL; Ong YY
    Singapore Med J; 2001 Feb; 42(2):85-8. PubMed ID: 11358199
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neuroleptic malignant-like syndrome causing thrombocytopaenia: a rare association.
    Sahu H; Manjunath MB; Ray A; Vikram NK
    BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30567175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neuroleptic malignant syndrome. Case reports].
    Berardi D; Troia M; Veronesi L; Ferrari G
    Minerva Psichiatr; 1994 Dec; 35(4):199-219. PubMed ID: 7861943
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic malignant-like syndrome with a slight elevation of creatine-kinase levels and respiratory failure in a patient with Parkinson's disease.
    Wei L; Chen Y
    Patient Prefer Adherence; 2014; 8():271-3. PubMed ID: 24600209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Neuroleptic malignant syndrome and atypical antipsychotics: a brief review].
    Khaldi S; Kornreich C; Choubani Z; Gourevitch R
    Encephale; 2008 Dec; 34(6):618-24. PubMed ID: 19081460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroleptic malignant syndrome. When levodopa withdrawal is the cause.
    Rainer C; Scheinost NA; Lefeber EJ
    Postgrad Med; 1991 Apr; 89(5):175-8, 180. PubMed ID: 2008397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Malignant syndrome in multiple system atrophy].
    Konagaya M; Goto Y; Matsuoka Y; Konishi T
    No To Shinkei; 1997 Jun; 49(6):516-20. PubMed ID: 9198091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Case report: Neuroleptic malignant syndrome and diagnostic difficulties].
    Khouri C; Planès S; Logerot S; Villier C; Mallaret M
    Encephale; 2016 Jun; 42(3):277-80. PubMed ID: 26923996
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neuroleptic malignant syndrome due to olanzapine.
    Hall KL; Taylor WH; Ware MR
    Psychopharmacol Bull; 2001; 35(3):49-54. PubMed ID: 12397878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuroleptic malignant syndrome in Parkinson's disease after withdrawal or alteration of dopaminergic therapy.
    Keyser DL; Rodnitzky RL
    Arch Intern Med; 1991 Apr; 151(4):794-6. PubMed ID: 1672810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenesis and treatment of neuroleptic malignant syndrome.
    Ebadi M; Pfeiffer RF; Murrin LC
    Gen Pharmacol; 1990; 21(4):367-86. PubMed ID: 1974219
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroleptic malignant syndrome-like, or--dopaminergic malignant syndrome--due to levodopa therapy withdrawal. Clinical features in 11 patients.
    Serrano-Dueñas M
    Parkinsonism Relat Disord; 2003 Jan; 9(3):175-8. PubMed ID: 12573874
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biochemical alterations during medication withdrawal in Parkinson's disease with and without neuroleptic malignant-like syndrome.
    Ueda M; Hamamoto M; Nagayama H; Okubo S; Amemiya S; Katayama Y
    J Neurol Neurosurg Psychiatry; 2001 Jul; 71(1):111-3. PubMed ID: 11413275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistant neuroleptic malignant syndrome and the role of electroconvulsive therapy.
    Hashim H; Zeb-un-Nisa ; Alrukn SA; Al Madani AA
    J Pak Med Assoc; 2014 Apr; 64(4):471-3. PubMed ID: 24864649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroleptic-induced catatonia: clinical presentation, response to benzodiazepines, and relationship to neuroleptic malignant syndrome.
    Lee JW
    J Clin Psychopharmacol; 2010 Feb; 30(1):3-10. PubMed ID: 20075641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuroleptic-induced extrapyramidal symptoms with fever. Heterogeneity of the 'neuroleptic malignant syndrome'.
    Levinson DF; Simpson GM
    Arch Gen Psychiatry; 1986 Sep; 43(9):839-48. PubMed ID: 2875701
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.